Hepatitis B virus e antigen (HBeAg) derived from liver at autopsy or from the serum of asymptomatic carriers has been characterized. The liver-derived HBeAg consisted of two different molecules, one with a mol. wt. of 30000 (monomer) and the other with a mol. wt. of 90000 (trimer), in a ratio of 3 : 1. Both were free of IgG. The serum-derived HBeAgs were heterogeneous with mol.
INTRODUCTION
A third antigen (HBeAg) associated with infection by hepatitis B virus (HBV) is distinct from the hepatitis B surface antigen (HBsAg) and the core antigen (HBcAg) (Magnius & Espmark, 1972; Takahashi et aL, 1978) . Those HBsAg-positive sera containing HBeAg are known to contain a large number of Dane particles and to have high DNA polymerase activity (Nordenfelt & Kjellen, 1975; Maynard et al., 1976) .
The close physical correlation between HBeAg and Dane particles has been examined (Ohori et al., 1979; Takahashi et al., 1979; Yoshizawa et al., 1979; Ohori et al., 1980) and HBeAg is now known to be an integral component of core particles in a cryptic form Ohori et al., 1980) .
As for the IgG-associated HBeAgs, the earlier work of Neurath & Strick (1977) indicated that HBeAg, partially purified from the pooled serum of asymptomatic carriers, had the properties of human immunoglobulin, mainly of the IgG4 subclass. Fields et al. (1978) and Weft et al. (1979) have also shown that HBeAg might be closely associated with human serum IgG. However, recent experiments indicated two different entities of HBeAg, one in a free form and the other bound to IgG (Takahashi et al., 1978; McAuliffe & Purcell, 1978; Neurath et aL, 1979) . In an earlier report from our laboratory (Yamada et al., 1979) it was demonstrated that there were some heterogeneities of serum HBeAg in terms of the mol. wt. and the isoelectric point (pI). More heterogeneities were found in HBeAg obtained from sera of those patients undergoing haemodialysis in whom a higher titre of virus activity was detected than in those from asymptomatic carriers. The latter characteristically have low titres of HBsAg, HBcAg, HBeAg and DNA polymerase activity in their sera. These results indicate that the physicochemical heterogeneity of HBeAg in the serum may reflect the virus activity in the liver.
Based on these considerations the following questions may be raised: (i) as well as the occurrence of the cryptic form of HBeAg inside core particles, is there also a free form of HBeAg to be found in the liver, and (ii) what kinds of serum proteins bind to HBeAg? In order to answer these questions, it is necessary to examine in more detail the physicochemical properties of all species of HBeAgs so far detectable in the liver and in serum. A detailed examination of the heterogeneities of serum and liver HBeAgs is presented and a hypothetical model describing the heterogeneity of HBeAg is discussed.
METHODS

Serological testing.
HBeAg was determined and titrated by immunodiffusion in agarose gel (Magnius & Espmark, 1972) . Standard HBeAg and anti-HBe reagents were obtained from HBsAg-positive donors as reported previously (Yamada et al., 1979) . Although the standard HBeAg contained the Williams e I and e2 antigen reactivities (Williams & Le Bouvier, 1976; Yamada et al., 1979) , the present study was conducted in order to purify the e 2 antigen.
Agarose plates were made from 0.8% agarose (Nakarai, Kyoto, Japan) dissolved in tris-NaC1 buffer pH 7-5 containing 0.1 M-tris-HC1, 0.1 M-NaCI, 0.01 M-EDTA, 2% polyethylene glycol 6000 (average mol. wt. 7500; Wako, Osaka, Japan) and 0.01% sodium azide. The titres of HBsAg and HBcAg were determined by the reversed passive haemagglutination (R-PHA) method (Ohori et al., 1979) .
Preparation of lgG-associated and lgG-free HBeAgs. The serum samples of asymptomatic carriers of HBsAg with a high titre of HBeAg were selected, pooled and used for the purification of serum-derived HBeAg. The purification was carried out by a combination of salting-out precipitation, ion-exchange chromatography, affinity chromatography~ gel filtration and isoelectric focusing. Each 300 ml portion of serum was first centrifuged at 10000 g for 30 min at 4 °C and the particles (small spherical, tubular-form and Dane particles) in the resulting supernatant were further centrifuged at 124000 g for 3 h in a Hitachi RP-42 rotor. The supernatant of this final centrifugation was used as the starting material. The first step in the separation of IgG-associated and IgG-free HBeAgs was performed by salting-out precipitation. Saturated (NH4)2SO 4 solution was added to 300 ml serum to a final concentration of 1.33 M and stirred for 1 h at 4 °C. The precipitate was separated by centrifugation at 10000 g for 30 min at 4 °C. The resulting precipitate which contained about 80% of the original HBeAg was dissolved in tris-NaCl buffer. Saturated (NH4)2SO4 was added to the supernatant to a final concentration of 3.24 M and a precipitate containing 20% of the original HBeAg was obtained. No detectable HBeAg was found in the supernatant.
In the second step, a DEAE-Sepharose CL-6B chromatography column was used to separate the IgG-associated from IgG-free HBeAgs. Each 1.33 M-and 3.24 M-(NH4)2SO 4 precipitate was dialysed against 0.01 M-citrate buffer pH 5.8 and the precipitate formed during dialysis was centrifuged and discarded. Each 150 ml portion of dialysed preparation was applied separately to a DEAE-Sepharose CL-6B column (6 x 70 cm) previously equilibrated with the 0.01 M-citrate buffer and then eluted (30 ml/h) with the same buffer until the protein became undetectable. The HBeAg-positive fractions were pooled and concentrated and were termed the '0.01 M-citrate eluate'. In the next step an elution was made with 0.04 M-citrate buffer pH 5.8; again the positive fractions were pooled and concentrated and termed the '0.04 u-citrate eluate'. In total, a 96 % recovery of HBeAg was obtained by these two elution steps. The 1.33 M-(NH4)2SO4 precipitate + 0.01 u-citrate eluate contained a large amount of IgG-associated HBeAg and no IgG-free HBeAg, whereas the 3.24 M-(NH4)2SO 4 precipitate + 0.04 M-citrate eluate contained either HBe(a)Ag or IgG-free HBeAg only. Immunoglobulin that contaminated the 0.01 M-citrate eluate was removed by DEAE-cellulose (DE52) column (2.6 × 30 cm) chromatography. The 0.01 M-citrate eluate was dialysed against 0-01 u-phosphate buffer (PB) pH 7.8 and an aliquot of the sample was applied to a column. When the column was washed (20 ml/h) with the same buffer, IgG contaminating the sample was eluted and discarded. All the HBeAg was eluted with 0.05 M-NaC1.
Liver-derived HBeAg was prepared by a combination of gel filtration and isoelectric focusing. The starting material was obtained from a 5 g autopsy liver sample of a patient suffering from subacute hepatitis (Ohori et al., 1980) . The tissue was minced into small fragments, homogenized in a SorvaU Omnimixer with 6 vol. chilled 20 mM-tris-HC1 pH 7.5 and centrifuged at 19000 rev/min for 30 min at 4 °C. The supernatant was further centrifuged at 123400 g for 12 h in a Hitachi RP50-2 rotor. Dane and core particles in the homogenate were completely pelleted.
Affinity chromatography. Thirty ml 0-04 M-citrate eluate (which was still contaminated with a small amount of serum IgG) was applied to a column (2 × 10 cm) of Sepharose 4B (Pharmacia) and conjugated with rabbit IgG prepared against human IgG. The column was first washed with 1000 ml tris-NaC1 buffer to obtain a 'pass-through' fraction and then adsorbed material was eluted with 3 M-ammonium thiocyanate. The HBeAg found in the pass-through fraction was not associated with human serum IgG and was used as the IgG-free serum HBeAg. The ratio of IgG-free and IgG-associated HBeAg was calculated as follows: each HBeAg fraction obtained from (NH4)2SO 4 salt precipitation of DEAESepharose CL-6B chromatography was applied to the column of Sepharose 4B conjugated with anti-human IgG. The titre of HBeAg in the pass-through fraction (IgG-free) and that of HBeAg in the 3 M-NH4SCN eluate (IgG-associated) were compared. The pass-through fraction was further chromatographed in a column (2 x 10 cm) of anti-human whole serum rabbit IgG or anti-human serum albumin rabbit IgG-conjugated Sepharose 4B to see if the serum components bound to these HBeAgs.
Gelfiltration. Gel filtration was used to discover the molecular heterogeneity of all HBeAgs and for futher purification. The sample was applied to a column (2.6 x 90 cm) of AcA 34 (LKB, Pleasant Hill, Ca., U.S.A.) which had been equilibrated with tris-NaCl buffer beforehand. Elution was at a flow rate of 15 ml/h and 3 ml fractions were collected. Samples used were (i) 0.05 M-NaC1 eluate from a DEAE-cellulose column, (ii) the pass-through fraction of affinity chromatography, and (iii) the supernatant fraction of liver homogenate. For the mol. wt. determination the following reference substances (gel filtration calibration kit, Pharmacia) were used: calf thymus thyroglobulin (669000), horse spleen ferritin (440000), horse liver catalase (210000), rabbit muscle aldolase (158000), bovine serum albumin (67000), ovalbumin (43000), bovine pancreas chymotrypsinogen (25000) and bovine pancreas ribonuclease A (13 700). Furthermore, gel filtration was conducted in the presence of 6 M-guanidine hydrochloride to see if the two species of either IgG-free serum HBeAgs or liver-derived HBeAgs are comprised of the same molecular size units. Purified IgG-free serum HBeAgs (0.04 u-citrate eluate of DEAE-Sepharose CL-6B column, anti-human IgG affinity chromatography and gel filtration) and liver-derived HBeAgs partially purified by gel filtration were dialysed against tris-NaC1 buffer containing 6 M-guanidine hydrochloride and applied to a column (1.6 x 80 cm) of Sephacryl S-200 (Pharmacia) which had been equilibrated with tris-NaC1 buffer containing 6 M-guanidine hydrochloride. The elution was made at a flow rate of 5 ml/h and 1.6 ml fractions were collected. E. YAMADA, H. OHORI AND N. ISHIDA
Immunoelectrophoresis. Immunoelectrophoresis was carried out as described by Grabar et al. (1960) . The gel was made of 1% agarose and 2% polyethylene glycol 6000 in barbital buffer (pH 8.6, 3/2 0.05). A 25 /A sample was electrophoresed at 4 V/cm until the bromophenol blue (BPB) marker had moved 4.2 cm. After electrophoresis, each trough was filled with anti-HBe serum and incubated for 48 h in a humid environment at room temperature.
Isoelectric focusing. HBeAg (partially purified by gel filtration) was applied to the Ampholine carrier ampholite column (LKB Model 8192, bed vol. 1 I0 ml) and a pH gradient ranging from 3.5 to I0 was established by applying 700 V for 48 h at 4 °C. (Weber & Osborn, 1969) was performed to discover the peptide composition of HBeAg and to find the ratio of HBeAg peptide to the H or L chain polypeptide of IgG with IgG-associated antigens. Lyophilized samples were dissolved in 8 M-urea containing 1% SDS, 5% 2-mercaptoethanol and 0.025% BPB and incubated at 37°C for 10 h and electrophoresed in 10% gel containing 4 M-urea. Mol. wt. were estimated using the following: rabbit muscle phosphorylase b (94 000), bovine serum albumin (67 000), ovalbumin (43 000), bovine erythrocyte carbonic anhydrase (30000), soybean trypsin inhibitor (20 100) and bovine milk a-lactalbumin (14 400) (all from the Pharmacia electrophoresis calibration kit). Electrophoresis was carried out at 6 mA/tube for about 6 h at room temperature. The gels were stained with 0.25 % (w/v) Coomassie Brilliant Blue (R-250)in a methanol-acetic acid mixture.
SDS-polyacrylamide gel electrophoresis. SDS-polyacrylamide gel electrophoresis (SDS-
PAGE)
Separation of HBeAg from IgG-associated HBeAg. The IgG-associated HBeAg which
was obtained from successive purifications (0.01 M-citrate eluate of DEAE-Sepharose CL-6B column, DEAE-cellulose chromatography and gel filtration) was dialysed against 0.01 M-PB pH 7.8 containing 5 M-or 8 M-urea. Then the treated sample was applied to the DEAE-Sepharose CL-6B column (1.5 × 8 cm) which had been equilibrated with PB pH 7.8 containing 5 M-or 8 M-urea. The column was first washed with PB to obtain a pass-through fraction. Stepwise elutions were made with 0.05, 0.07 and 0.1 M-NaC1 in PB to obtain 1 ml fractions.
RESULTS
Preparation and purification of different types of HBeAgs derived from serum and liver
For the purification of HBeAg from serum and liver Dane particles and free core particles were first removed by repeated centrifugation of the starting material. The supernatants were checked by serological methods and electron microscopy (Ohori et al., 1979 (Ohori et al., , 1980 and no HBsAg. HBcAg or Dane particles were detected. Thus, HBeAg was purified from supernatants negative for other markers of hepatitis B.
When the first purification trial was conducted by salting-out with (NH4)2SO 4 approx. 80% of the HBeAg titre was recovered in the 1.33 M-(NH4)2SO 4 precipitate and the remaining 20% in the 3.24 M-(NH4)2SO 4 precipitate, suggesting a molecular heterogeneity of the HBeAg contained in the serum. Almost 90% of the HBeAg in the 1.33 M-(NH4)2SO4 precipitate and 80% in the 3.24 M-(NH4)2SO 4 precipitate were the IgG-associated and the IgG-free HBeAg respectively. Further purification of these two HBeAg specificities was accomplished by DEAE-Sepharose CL-6B chromatography. When either the 1.33 M-or the 3.24 M-precipitate was applied to the column, followed by stepwise elution With 0.01 M-and 0.04 M-citrate buffer pH 5.8, the elution profiles of HBeAg in the 1. Heterogeneity of HBeA g 79 M-precipitate was found to be the IgG-free HBeAg. These results indicate that the HBeAg in the 1.33 M-precipitate is mainly associated with serum IgG, but the antigen in the 3.24 M-precipitate is more acidic and may be IgG-free HBeAg.
The fraction eluted with 0.01 M-citrate was further purified by DEAE-cellulose column chromatography. Serum IgG contaminating this fraction was separated in the first peak by elution with 0.01 M-PB pH 7.8. As a small amount of serum IgG was present in the 0.05 M-NaC1 eluate, further purification was carried out by gel filtration and isoelectric focusing (see below).
Association of HBeAg with albumin
For further purification of IgG-free HBeAg, the 0.04 M-citrate eluate was applied to an affinity column of anti-human IgG. Approx. 90% of the HBeAg passed through, indicating that the majority of HBeAg in the 0.04 M-citrate eluate is not associated with IgG.
When the material which passed through the anti-human IgG affinity column was applied to an affinity column of rabbit IgG made against unfractionated human serum, approx, half of the HBeAg passed through and the remaining 50% was adsorbed. When eluted, the latter was shown to react with anti-human serum albumin in agar-gel immunodiffusion and almost 100% bound to an affinity column of anti-human serum albumin (data not shown). On the other hand, almost 100% of the HBeAg obtained through the DEAE-cellulose chromatography of the 0-01 M-citrate eluate was adsorbed to the anti-human IgG and anti-human whole serum affinity column.
From these results, we conclude that there are three types of HBe-Ags present in serum, one associated with human serum IgG, a second with albumin and a third type which is free from serum components.
Mol. wt. of serum-derived and liver-derived HBeAgs
Purified IgG-associated HBeAg [1.33 M-(NH4)2SO 4 precipitation, DEAE-Sepharose CL-6B (0.01 M-citrate eluate) and DEAE-cellulose chromatography] was examined for molecular heterogeneity on an AcA 34 column. As shown in Fig. 1 (a) the fraction positive for HBeAg was eluted before the monomeric IgG, which contaminated the 0.05 M-NaC1 eluate from the DEAE-cellulose. Three peaks of HBeAgs were obtained of molecular sizes about 240 000, 400 000 and 540 000.
The molecular size of the fraction which did not adsorb to the anti-human IgG affinity column [originating from the 3.24 M-(NH4)2SO 4 precipitate and subsequently eluted with 0.04 M-citrate from the DEAE-Sepharose CL-6B column] was determined in the same way and shown in Fig. 1 (b) . Two molecular sizes of 90000 and 30000 were observed in a ratio of about 9:1. Of these, only HBeAg having a tool. wt. of 90000 was adsorbed to anti-human albumin, suggesting that at least a part of this sized HBeAg was associated with serum albumin (data not shown).
Supernatant from liver homogenate was also applied to the same AcA 34 column (Fig. 1 c) . The HBeAg-positive fractions were eluted at the mol. wt. of 90000 and 30000 in a ratio of 1:3. Neither were adsorbed by an anti-human albumin column indicating that this HBeAg was free from serum albumin.
Gel filtration on Sephacryl S-200 in tris-NaCl buffer was conducted in the presence of 6 M-guanidine hydrochloride to see if both the mol. wt. 90000 and 30000 components from liver and serum are comprised of the same molecular size units. Only one molecular size (mol. wt. 24000 to 26000) peak was observed indicating that the 90000 peak is a trimer of mol. wt. approx. 30000. Fig. 1 a) , (b) albumin-associated HBeAg (mol. wt. 90000) from serum (peak IV, Fig. 1 b) , (c) free HBeAg (mol. wt. 90000) from liver (peak V, Fig. 1 c) and (d) free HBeAg (moL wt. 30000) from liver (peak VI, Fig. 1 c) . Troughs contain human serum IgG containing anti-HBe. Fig. 1 (b) , (b) free HBeAg from liver (peak V, fraction no. 85 to 98) in Fig. 1 (c) and (c) free HBeAg from liver (peak VI, fraction no. 100 to 120) in Fig. 1 (c) . Fig. 2 shows immunoelectrophoresis of four different HBeAgs, obtained from gel filtration of the AcA 34 column. The IgG-associated serum HBeAg from the pooled fraction of peak I (mol. wt. 540000), II (400000) and III (240000) in Fig. 1 (a) gave a precipitin band in the flto ),-globulin region (Fig. 2a) . Peak IV in Fig. 1 (b) corresponding to the albumin-associated serum HBeAg of molecular size 90000 was found in the a-globulin region (Fig. 2b) . Peaks V and VI in Fig. 1 (c) (liver homogenate, mol. wt. 90000 and 30000) migrated to the furthest a-globulin region (Fig. 2 c, d ).
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Electrophoretic mobilities of IgG-associated HBeAgs in comparison with those of IgG-free HBeAgs
Isoelectric point of IgG-associated and IgG-free HBeA gs
In a previous report (Yamada et al., 1979) , we demonstrated that there was an association between the mol. wt. and the isoelectric point among heterogeneous HBeAgs. In a more detailed analysis of the peaks I, II and III found in Fig. 1 (a) fractions were subjected to isoelectric focusing and I-IBeAg was recovered at pH 6-4 to 8.4 (Fig. 3a) , 5.7 to 8 (Fig. 3b) and 5.5 to 7-5 (Fig. 3c) . In a similar analysis HBeAg obtained from peak IV in Fig. 1 (b) (the albumin-associated serum HBeAg) was recovered at pH 4.4 to 5.1 (Fig. 4a) . A similar, but slightly narrower isoelectric point of 4.3 to 4.8 was obtained when the two free HBeAgs (peak V and VI, from liver) were examined ( Fig. 4b and 4 c  respectively) .
The results show that monomers and trimers obtained from liver and serum have a similar pI, although the ratio of trimer to monomer was higher in the blood stream than in the liver, and that the HBeAgs associated with IgG have a higher pI.
Molecular ratios of IgG-associated HBeAg
The ratio of IgG to the HBeAg in peak I (mol. wt. 540000), peak II (400000) and peak III (240000) from Fig. i (a) was determined by analysis of their peptide composition (Fig. 5) . Three major polypeptide bands were obtained, two co-migrating with the H and L chains of IgG and the third, presumably HBeAg with a mol. wt. of about 21000. Other peaks of mol. wt. 43 000 and about 80000 were present but their ratios to the 21000 peak were less in peak III than in peak I. The relative ratios of HBeAg to the H + L chain of IgG were 1 : 3, 1 : 2 and 1:1 in peak I (Fig. 5 a) , II (Fig. 5 b) and III (Fig. 5 c) respectively. These results strongly suggest that the molecular sizes of the three IgG-associated HBeAgs depend upon the number of IgG molecules attached to HBeAg.
Partial dissociation of IgG molecule from IgG-associated HBeAg by urea treatment
IgG-associated HBeAg was examined to see if this was an immune complex. Purified IgG-associated HBeAg obtained from pooled peaks I, II and III (Fig. 1 a) (Fig. 6 a) . In samples treated with 5 M-urea HBeAg was eluted with 0.05 M-NaC1, 0.07 M-NaC1 and 0.1 M-NaCI (Fig. 6 b) . Some free IgG was eluted in the pass-through fraction. When the same sample was subjected to 8 M-urea treatment HBeAg was recovered only in the 0.1 M-NaC1 fraction (data not shown), but only 70 % of initial HBeAg titre was recovered.
DISCUSSION
In serum of asymptomatic hepatitis B carriers, HBeAg can be detected in two different forms (Takahashi et al., 1978; McAuliffe & Purcell, 1978; Neurath et al., 1979) either associated with IgG or free from IgG. The former is associated with an electrophoretic mobility in the fl-to y-globulin region and the latter in the a-globulin region (Fig. 2) . We have confirmed the observations of Takahashi et al. (1978) in this work and have presented new data on heterogeneity of HBeAgs obtained from liver and serum. These are summarized in a hypothetical model (Fig. 7) which is discussed below.
When an autopsy liver specimen containing a large number of free cores was centrifuged at 123400 g for 12 h, the supernatant did not contain any HBsAg, HBcAg or detectable DNA p01ymerase activity (data not shown), although the precipitate contained cores from which HBeAg in a cryptic form could be extracted (Ohori et al., 1980) . This supernatant contained HBeAg with molecular sizes of 30000 and 90000 (Fig. 1 c) . Both of these molecules banded at pH 4.3 to 4.8 (Fig. 4 b, c) , and had an electrophoretic mobility in the a-globulin region (Fig.  2c, d ). Evidence is presented that HBeAg of mol. wt. 90000 is a trimer of a monomeric HBeAg. It should also be noted that in this liver homogenate no IgG-associated nor any albumin-associated HBeAgs were detected. Such free HBe(a)Ags were also found in serum but the proportion oftrimers to monomers was greater in serum than in liver (Fig. 1 b, c) Some HBeAgs from the serum were associated with albumin. These had a mol. wt. of 90000 (Fig. 1 b) and pI of 4.4 to 5.1 (Fig. 4a) . Evidently, albumin did not greatly affect the pI. It is possible that there is one molecule of albumin (mol. wt. 60 000) per one molecule of monomer HBeAg (mol. wt. 30000). Affinity chromatography indicates that this HBeAg is free from IgG and is an approximately equal mixture of albumin-associated and albumin-free HBeAgs. Whether such albumin-associated HBeAg is produced in the liver or in the blood stream is not known although no albumin-associated HBeAg was detected in the liver homogenate (Fig. 7) .
IgG-associated HBeAgs with mol. wt. of 540000 (pI 6.4 to 8.4; Fig. 3 a) , 400000 (pI 5.7 to 8; Fig. 3b ) and 240000 (pI 5.5 to 7.5; Fig. 3c ) were also detected in sera. Neurath & Strick (1977) demonstrated that the pI of anti-HBe IgGs were heterogeneous, having the pI range from 5.8 to 10.2. Therefore, the heterogeneity in pI of IgG-associated HBeAg may result from the different number of IgG molecules which bind to HBeAg. The mol. wt. of peak HI (240000) suggests that it could consist of one molecule of IgG (mol. wt. 160000) and a trimer of HBeAg (mol. wt. about 90 000). In the same manner, peak II consists of two moles of IgG plus one mole of the trimer HBeAg, and peak I three moles of IgG plus one mole of the trimer HBeAg (Fig. 7) . The ratios of H or L chain polypeptides to the HBeAg polypeptide support this view (Fig. 5 a to c) . When the number of IgG molecules associated with the antigen increased an alkaline shift of pI values was evident (Fig. 3) .
Evidence that the above IgG was specific anti-HBeAg is provided by the failure of 5 M-urea to completely dissociate IgG from the complex (Fig. 6) . Furthermore, when IgG-associated HBeAg was chromatographed on Sephacryl S-200 in buffer containing 6 ra-guanidine hydrochloride, the IgG fraction which was eluted at the position of mol. wt. 160000 was found to have anti-HBe activity by radioimmunoassay. In addition, the smaller mol. wt. fraction (24 000 to 26 000) exhibited HBeAg activity (data not shown). Kunkel et al. (1961) reported the partial dissociation of immune complexes of 7-globulin and anti-?-globulin in 4 M-urea and complete dissociation in 6 M-urea. Therefore we consider that the IgG associated with the HBeAg molecule forms a true immune complex rather than a non-specific association between HBeAg and IgG. It is of interest that even the largest molecular HBeAg still has the antigenic sites which react with the antibody to HBeAg.
The peptide composition of HBeAg has been in dispute. McAuliffe & Purcell (1978) identified three peptides of mol. wt. 21000, 17 000 and 6000 to 9000 from HBeAg in serum. The peptide of mol. wt. 17000 may be the smallest unit of HBeAg (Neurath et al., 1979 ; In our experiments peptides of 21000, 43 000 and 80000 were detected by SDS-PAGE from various HBeAgs isolated from serum (Fig. 5) . However, there were insufficient of these to check their antigenicity. Hence, the physicochemical correlation between polypeptides found by SDS-PAGE and the monomeric protein unit of HBeAg (mol. wt. 30 000 by gel filtration) is not resolved. The model in Fig. 7 uses only 30000 
